Reece Thomas’ Post

🚀 New Disease Panel from Elixirgen Scientific 🧬 We are thrilled to announce the launch of our groundbreaking human  iPSC-derived neuron disease panel from Alzheimer's Disease (AD) donors! This innovative panel includes multiple distinct AD donor and  control cell lines, providing researchers with unparalleled resources for Alzheimer's Disease research and drug development. Our panel is designed to empower researchers with advanced tools for predictive testing of drug candidates. By leveraging our transcription-factor based iPSC technology, these models recapitulate disease phenotypes for more accurate disease modeling in vitro. Discover how our iPSC-derived disease panel can accelerate your research and streamline your drug development process. Learn more: https://lnkd.in/gc6X8WKN #Biotech #Alzheimer’s #Alzheimer’sResearch #Alzheimer’sDisease #iPSC #DrugDevelopment #Biotechnology #PredictiveTesting

🌟 Breakthrough Insights: IL1A and Autoimmune Diseases! 🧬 We’re excited to share our latest research on IL1A, investigating its role in inflammatory processes and immune responses. Our case-control study explores its association with rheumatoid arthritis and Alzheimer's disease, aiming to develop new therapeutic strategies for autoimmune disorders. This important work, achieved in collaboration with BioTrust labs and the Enzyme team, is driving us towards innovative treatments and a better understanding of autoimmune health. The enclosed picture is part of our meeting with Thermo Fisher to discuss how to gain more insights and execute this project in our own facility, with our own hands, using our advanced genomics platforms! 📊🔍 #IL1A #AutoimmuneResearch #Genomics #RheumatoidArthritis #AlzheimersDisease #HealthcareInnovation #Biotech #ScientificDiscovery

Precision medicine is revolutionizing healthcare with personalized treatments based on genetic insights. By considering individual genes, environment, and lifestyle, it offers accurate strategies for treatment and prevention. Online collaborations, investments, and advances in cancer biology drive market growth. It's proactive healthcare at its best! 💡💊 Read more https://lnkd.in/g9tdYveU #precisionmedicine #personalizedmedicine #genomics #healthcareinnovation #medicalresearch #biotechnology #marketresearch #marketanalysis #precisiononcology #healthtech #industryinsights #markettrends #consumerresearch #businessintelligence #patientcare #precisiontherapeutics

Advancements in lupus research are paving the way for improved patient care through precision medicine, biological therapies, biomarker discovery, and patient-centered approaches. Exploring the gut microbiome's role opens new therapeutic avenues. Collaboration among all stakeholders is key to realizing these potential breakthroughs. https://lnkd.in/duD5wnpq #LupusResearch #PrecisionMedicine #BiologicalTherapies #Biomarkers #PatientCare Dipti Gogate

Metabolomics holds the key to understanding disease at the molecular level. By mapping the intricate web of metabolic pathways, we uncover breakthrough biomarkers and pave the way for personalized therapies. This is the next frontier in disease research and treatment. Let us help you reach your research goals and transform healthcare through cutting-edge metabolomics! #dataanalysis #omics #metabolomics #massspectrometry #machinelearning #Biomarkers #cancers

Enjoyed my first time attending #CGMesa24 in PHX with Gina Black, MBA. Great to learn more about ongoing efforts to make cell and gene treatments further accessible (as thoughtfully as possible) to patients, physicians, and institutions across the board. We were fortunate enough to meet some incredibly smart and passionate people who were already hard at work on it. Charismatic speaker panels and moderators drove well-considered discussions with thoughtleaders from all stakeholders. There was also an incredible patient testomonial that was a stark reminder on how much extra room there is to enhance the patient experience. Looking forward to attending future events, from a market access viewpoint some topics really hit home: ⁃ Rethinking of patient journeys beyond traditional parameters ⁃ Downstream benefits of market access strategy 1-2 years ahead of PDUFA / prior to publication of pivotal study ⁃ Urgency to ease academic/community hospital burdens of all imagineable forms so they can instead focus on patient care (for example: product portals are necessary, and do work fine, but yet apparently are not a favorite thing?🙂)

Untargeted proteomic analysis on cerebral spinal fluid from cerebral amyloid angiopathy (CAA) using Evosep One and Bruker timsTOF Pro2 In this recent publication, the authors determined the detection of proteins related to cathepsin proteases and synaptic proteins could serve as potential diagnostic biomarkers for CAA to aid in early diagnosis and monitoring of disease progression. Read the full manuscript here https://lnkd.in/eAGCijWX To learn more about the Evosep One platform, visit our website www.evosep.com or contact me for more information. #evosep, #bruker, #timsTOF, #proteomics, #CSF, #biomarkers

Degenerative retinal diseases, characterised by photoreceptor loss are a significant cause of global visual impairment. However, there are few treatment options available for these diseases. We are excited to share a recent study using our TRC research chemicals to identify a therapeutic small molecule via phenotypic screening. The study demonstrates efficacy in preclinical disease models, providing promising proof-of-concept results. Learn more about the study published in the International Journal of Molecular Science: https://okt.to/RJP9gj #ProductCitation #ResearchChemicals #ScienceforaSaferWorld

𝗜𝗻𝘁𝗲𝗿𝘃𝗶𝗲𝘄: 𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗦𝘁𝗲𝗿𝗼𝗶𝗱 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗮𝗻𝗱 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 Discover how the Steroid Metabolome Analysis Core (SMAC) team at the University of Birmingham is revolutionising endocrine research. In this exclusive video series, Dr Angela Taylor, Dr Fozia Shaheen, and Dr Joshua Bain share insights on: 🔍 Identifying Novel Biomarkers 📊 Simplifying Large-Volume Data Analysis 🩺 Driving Clinical Impact Learn how they’re pushing boundaries in steroid metabolism and improving patient outcomes through advanced diagnostics. Watch the full interviews here: https://lnkd.in/e3Q722Jv #SteroidResearch #ClinicalDiagnostics #GCMS

Yesterday, DefiniGEN’s Founder and CSO Prof. Ludovic Vallier gave an illuminating and insightful seminar: "Understanding Human Organogenesis to Develop Therapies Against Liver Diseases." The talk covered his research into molecular mechanisms governing liver development, focusing on the generation of #cholangiocytes and #hepatocytes. Specifically, he shared how his team is investigating the mechanisms driving progression of non-alcoholic fatty liver disease and how these insights could help develop new regenerative therapies. If you missed this talk, fear not! You can visit our website to learn more about how DefiniGEN’s OPTI-Hep platform can accelerate your research into liver disease modelling and drug screening: https://lnkd.in/eRVXmF4U   #BiomedicalResearch #LiverDisease #StemCellResearch #Liver #BabrahamInstitute